Cargando…

Predictors of biologic treatment of psoriasis: a non-interventional study

BACKGROUND: Biologic therapies represent a significant advance in the treatment of psoriasis. However, no studies have examined the patient characteristics predictive of biologic treatment of psoriasis. The purpose of this study was to ascertain the frequency and predictors of treatment of psoriasis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puig, Luis, Fan, Tao, Ding, Qian, Smith, Nancy E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933358/ https://www.ncbi.nlm.nih.gov/pubmed/24600238 http://dx.doi.org/10.2147/CEOR.S54797

Ejemplares similares

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
por: Warren, R.B., et al.
Publicado: (2018)

Patient preference for biologic treatments of psoriasis in Japan
por: Tada, Yayoi, et al.
Publicado: (2019)

Comparison of Treatment Goals between Users of Biological and Non-Biological Therapies for Treatment of Psoriasis in Japan
por: Okubo, Yukari, et al.
Publicado: (2021)

Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
por: Lallas, Aimilios, et al.
Publicado: (2016)

Patient Preference for Biologic Treatments of Psoriasis in the Chinese Setting
por: Lang, Yitian, et al.
Publicado: (2022)

Predicting treatment success with biologics in psoriasis
por: van den Reek, J.M.P.A.
Publicado: (2019)

Biologic Treatments of Psoriasis: An Update for the Clinician
por: Brownstone, Nicholas D, et al.
Publicado: (2021)

Neurological Complications of Biological Treatment of Psoriasis
por: Ożóg, Mateusz Kamil, et al.
Publicado: (2022)

Advancements in the Treatment of Psoriasis: Role of Biologic Agents
por: Rich, Sheldon J., et al.
Publicado: (2004)

The cost of biologics for psoriasis is increasing
por: Cheng, Judy, et al.
Publicado: (2014)

Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
por: Armstrong, April W., et al.
Publicado: (2021)

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
por: Schmitt-Egenolf, Marcus, et al.
Publicado: (2021)

Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council
por: Cohen, Arnon D., et al.
Publicado: (2020)

Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study
por: SCHWARZ, Christopher Willy, et al.
Publicado: (2021)

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
por: Jiang, Yuxiong, et al.
Publicado: (2023)

Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study
por: Robinson, Suganthy, et al.
Publicado: (2023)

Treatment Options and Goals for Patients with Generalized Pustular Psoriasis
por: Krueger, James, et al.
Publicado: (2022)

Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
por: Yu, Chen, et al.
Publicado: (2022)

BIOLOGICAL THERAPY OF PSORIASIS
por: Sivamani, Raja K, et al.
Publicado: (2010)

Biologics in the management of psoriasis
por: Bahner, Jennifer D, et al.
Publicado: (2009)

Biologics and Biosimilars in Psoriasis
por: Ahmed, Sk Shahriar, et al.
Publicado: (2023)

Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis
por: Andersen, Clara Sophie Bramsen, et al.
Publicado: (2023)

Biological drugs for the treatment of psoriasis in a public health system
por: Lopes, Luciane Cruz, et al.
Publicado: (2014)

An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK
por: Green, William, et al.
Publicado: (2021)

Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment
por: Rivera-Díaz, Raquel, et al.
Publicado: (2023)

Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab
por: Garcia-Valladares, Ignacio, et al.
Publicado: (2011)

Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis
por: Barker, Jonathan, et al.
Publicado: (2021)

Biological markers in the etiology of psoriasis: Targeted treatment options
por: de Felice, Catia, et al.
Publicado: (2007)

Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
por: Papoutsaki, Marina, et al.
Publicado: (2009)

Quo vadis, biological treatment for psoriasis and psoriatic arthritis?
por: Olszewska, Barbara, et al.
Publicado: (2018)

Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis
por: Cline, Abigail, et al.
Publicado: (2019)

Improving patient outcomes in psoriasis: strategies to ensure treatment adherence
por: Yélamos, Oriol, et al.
Publicado: (2015)

Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis
por: Strohal, R, et al.
Publicado: (2014)

Development of an mHealth App for Patients With Psoriasis Undergoing Biological Treatment: Participatory Design Study
por: Trettin, Bettina, et al.
Publicado: (2021)

Treatment of Psoriasis
por: Panja, D., et al.
Publicado: (1935)

The biological basis of disease recurrence in psoriasis: a historical perspective and current models
por: Puig, Lluís, et al.
Publicado: (2022)

Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis
por: Iskandar, I.Y.K., et al.
Publicado: (2017)

Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis
por: Armstrong, April, et al.
Publicado: (2022)

Pathophysiology of Generalized Pustular Psoriasis
por: Marrakchi, Slaheddine, et al.
Publicado: (2022)

Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis
por: Puig, Lluís
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m7m3skonei9l2qeav5m1vbujaa